STAT+: ASCO Daily Recap: AstraZeneca’s hat trick, a GSK turnaround, and palliative care as telehealth
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up here.
Another big win for Enhertu
The stuff I do for you, dear readers, because I love you: Work until 10:30 p.m. on Saturday night to finish a story on the Enhertu “ultra low HER2” breast cancer data from the Destiny-Breast06 trial. And then get up at the crack of dawn Sunday to attend the 7:30 a.m. special session that ASCO scheduled to show the data to the world.
No thanks needed, except of course, please read the Enhertu story that I worked so hard to write!
